more

PerkinElmer, Inc. (PKI)

(Delayed Data from NYSE)

$96.59 USD

+1.71 (1.80%)

Updated May 3, 2019 04:03 PM ET

After-Market: $96.59 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.15%
2	Buy	17.88%
3	Hold	9.47%
4	Sell	5.14%
5	Strong Sell	2.57%
S&P	500	11.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

Industry: NA

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

PerkinElmer (PKI) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research Published on January 26,2021

PerkinElmer (PKI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PKIPositive Net Change

Top Ranked Growth Stocks to Buy for January 21st

by Zacks Equity Research Published on January 22,2021

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 21st

Zacks Industry Outlook Highlights: Mettler-Toledo International, Waters Corp, PerkinElmer and Bruker

by Zacks Equity Research Published on January 22,2021

Zacks Industry Outlook Highlights: Mettler-Toledo International, Waters Corp, PerkinElmer and Bruker

tech-stocks

3 Reasons Why PerkinElmer (PKI) Is a Great Growth Stock

by Zacks Equity Research Published on January 21,2021

PerkinElmer (PKI) is well positioned to outperform the market, as it exhibits above-average growth in financials.

PKIPositive Net Change

Why PerkinElmer (PKI) Could Beat Earnings Estimates Again

by Zacks Equity Research Published on January 21,2021

PerkinElmer (PKI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

PKIPositive Net Change

Perion (PERI) Announces Encouraging Preliminary Q4 Results

by Zacks Equity Research Published on January 21,2021

Perion Network (PERI) posts upbeat fourth-quarter and 2020 preliminary financial results, on the back of strength in the advertising business and synergies from recent acquisitions.

4 Stocks to Watch on Rising Demand for Scientific Instruments

by Aniruddha Ganguly Published on January 21,2021

The Zacks Instruments - Scientific industry is gaining from strong life science, pharmaceutical and academic end-market demand. Industry participants MTD, WAT, PKI, and BRKR are set to gain from rising healthcare spending and exposure to developing economies like China and India.

Why You Should Retain Pacific Biosciences (PACB) Stock Now

by Zacks Equity Research Published on January 20,2021

Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of solid prospects.

Top Ranked Growth Stocks to Buy for January 20th

by Zacks Equity Research Published on January 20,2021

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 20th

3 Biggest MedTech Trends to Watch in 2021 for Better Returns

by Sriparna Ghosal Published on January 20,2021

Following are the three MedTech trends, which showed a steady momentum through the pandemic year and are likely to sustain even after the economic mayhem subsides.

medical

Omnicell (OMCL) Reports Encouraging 2020 Preliminary Results

by Zacks Equity Research Published on January 19,2021

Per the preliminary announcement, Omnicell (OMCL) projects 2020 total revenues to surpass its previous guidance.

medical

PerkinElmer (PKI) Receives FDA EUA for Asymptomatic Testing

by Zacks Equity Research Published on January 18,2021

PerkinElmer's (PKI) RT-PCR assay to test individuals without COVID-19 symptoms acts as prime factor in controlling the spread.

medical

Intersect ENT's (XENT) Q4 Preliminary Revenues Disappointing

by Zacks Equity Research Published on January 18,2021

Per the preliminary announcement, Intersect ENT (XENT) projects Q4 revenues to decline from the year-ago quarter's reported figure.

medical

Thermo Fisher (TMO) Expands in Viral Vector With Henogen Buyout

by Zacks Equity Research Published on January 18,2021

The addition of Henogen's manufacturing capabilities in Europe complement Thermo Fisher's (TMO) four development and manufacturing sites in North America.